Physiological and pharmacodynamic considerations for route of EPO administration

被引：0
|
作者：
Besarab, A [1 ]
机构：
[1] Robert C Byrd Hlth Sci Ctr, Div Nephrol, Dept Med, Morgantown, WV 26506 USA
来源：
SEMINARS IN NEPHROLOGY | 2000年 / 20卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：364 / 374
页数：11
相关论文
共 50 条
  • [31] PHYSIOLOGICAL CONSIDERATIONS IN SEATING
    STEWART, CPU
    PROSTHETICS AND ORTHOTICS INTERNATIONAL, 1991, 15 (03) : 193 - 198
  • [32] EFFECTIVENESS OF ERYTHROPOIETIN (EPO) GIVEN VIA THE INTRAVENOUS (IV) ROUTE VERSUS THE SUBCUTANEOUS (SC) ROUTE
    WINGEIER, MJ
    PRASAD, PR
    PRASAD, J
    KOSANOVICH, J
    BROWN, G
    KONAL, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 484 - 484
  • [33] Pharmacokinetic and pharmacodynamic considerations of cephalosporin use in children
    Tauzin, Manon
    Ouldali, Naim
    Bechet, Stephane
    Caeymaex, Laurence
    Cohen, Robert
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (11) : 869 - 880
  • [34] Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose Optimization
    White, Nicholas J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) : 5792 - 5807
  • [35] Pharmacokinetic and Pharmacodynamic Considerations in the Development of Therapeutic Proteins
    Iftekhar Mahmood
    Martin D. Green
    Clinical Pharmacokinetics, 2005, 44 : 331 - 347
  • [36] ANESTHESIA FOR THE AGED - SOME PHARMACOKINETIC AND PHARMACODYNAMIC CONSIDERATIONS
    MILLER, R
    MOUNT SINAI JOURNAL OF MEDICINE, 1987, 54 (04): : 305 - 307
  • [37] Pharmacokinetic and Pharmacodynamic Considerations of Antibiotic Use in Neonates
    Regazzi, Mario
    Berardi, Alberto
    Picone, Simonetta
    Tzialla, Chryssoula
    ANTIBIOTICS-BASEL, 2023, 12 (12):
  • [38] Pharmacokinetic and pharmacodynamic considerations in antimicrobial therapy for sepsis
    Fujii, Motoki
    Karumai, Toshiyuki
    Yamamoto, Ryohei
    Kobayashi, Eri
    Ogawa, Kenta
    Tounai, Mayuko
    Lipman, Jeffrey
    Hayashi, Yoshiro
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (05) : 415 - 430
  • [39] Warfarin withdrawal - Pharmacokinetic-pharmacodynamic considerations
    Palareti, G
    Legnani, C
    CLINICAL PHARMACOKINETICS, 1996, 30 (04) : 300 - 313
  • [40] Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness
    Mehrotra, R
    De Gaudio, R
    Palazzo, M
    INTENSIVE CARE MEDICINE, 2004, 30 (12) : 2145 - 2156
12345